Search
for
Sort by
Research 571–600 of 1000+
- Characteristics of Hypertrichosis Induced by 24-week Low-dose (5 mg Daily) Oral Minoxidil in Male Pattern Hair Loss Treatment
- Molecular mechanism for transcriptional regulation of the parathyroid hormone gene by Epiprofin
- Low‐Dose Oral Minoxidil in Lichen Planopilaris: Efficacy and Safety
- From Hair Loss to Vision Loss: Minoxidil-Associated CRVO in a Young Female
- The promising prospect of human hair follicle regeneration in the shadow of new tissue engineering strategies
- Spironolactone
- The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date
- Efficacy of oral isotretinoin in the treatment of acne vulgaris
- Tebentafusp-tebn (Kimmtra®)
- Dermatological manifestations of COVID-19 and its therapies: a review
- Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis
- From Plants to Wound Dressing and Transdermal Delivery of Bioactive Compounds
- Randomized controlled trial to compare the efficacy of oral minoxidil 1.25 mg versus 2.5 mg versus topical 5% minoxidil in androgenetic alopecia
- Treatment options for polycystic ovary syndrome
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology
- Androgen insufficiency in women: diagnostic and therapeutic implications
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing
- From Diospyros kaki L. (Persimmon) Phytochemical Profile and Health Impact to New Product Perspectives and Waste Valorization
- Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature
- Pharmacology of Natural Volatiles and Essential Oils in Food, Therapy, and Disease Prophylaxis
- Application of Baricitinib in Dermatology
- Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
- The Future of Alopecia Treatment: Plant Extracts, Nanocarriers, and 3D Bioprinting in Focus
- Hydrogel-Forming Microneedles for Transdermal Drug Delivery